StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2022 - 11 - 08
1
2021 - 12 - 09
2
2021 - 07 - 20
1
2021 - 07 - 06
1
Sector
Communications
1
Health technology
5
Manufacturing
1
Tags
Agreement
6
Antibody
23
Approval
6
Authorized
7
Back
4
Biotech-beach
19
Brazil
6
Cancer
17
Ceo
6
China
4
Clearance
13
Clinical-trials-phase-ii
7
Commercialization
5
Company
10
Conference
14
Covid
35
Covid-19
16
Diagnostic
4
Distribution
4
Drop
6
Drug
11
Drug delivery
4
Enroll
7
Fda
21
Fda clearance
8
Financial
4
Infections
4
License
14
Liver
4
Market
6
Meeting
5
N/a
183
Opioid
5
Order
4
Osteoarthritis
4
Pharmaceuticals
6
Phase 1
10
Phase 1b
6
Phase 2
20
Phase 2b
8
Phase 3
8
Positive
19
Research
8
Results
28
Sars-cov-2
17
Solid tumors
4
Sp-102
4
Sp-103
5
Sti-1558
8
Sti-9167
4
Study
9
T-cell
4
Test
13
Therapeutics
22
Therapy
9
Treatment
37
Trial
33
Vaccine
8
Virpax
5
Ztlido
8
Entities
Nutriband inc.
1
Orange
1
Sorrento therapeutics, inc.
5
Symbols
ABBV
2
ABT
2
ADIL
4
ADMP
4
APTX
1
ATAI
2
AUTL
1
AZN
3
AZNCF
3
BHC
2
BHVN
1
BICX
7
BTAI
4
CAH
1
COLL
1
CYBN
1
EBS
4
ECOR
2
ENDP
2
ENSC
8
FNCTF
6
GLAXF
3
GSK
3
HROW
2
HRTX
2
INCY
2
IRWD
2
ITCI
1
JNJ
22
LH
1
LIVN
1
LLY
1
MASI
1
MCK
3
MDT
2
MESO
1
MNK
3
MNKKQ
3
MNKPF
3
MNMD
1
NAOV
2
NKTR
1
NLSP
1
NTRB
2
NVS
2
NVSEF
2
OPNT
5
PCRX
4
PFE
2
PMD
2
PPRUF
2
PPRUY
2
SCLX
1
SEEL
1
SNY
2
SNYNF
2
SRNE
5
TAK
2
TEVJF
3
VTRS
2
Exchanges
Nasdaq
5
Crawled Date
2022 - 11 - 08
1
2021 - 12 - 09
2
2021 - 07 - 20
1
2021 - 07 - 06
1
Crawled Time
12:00
1
17:00
2
19:00
1
22:00
1
Source
nutriband.com
1
www.biospace.com
1
www.globenewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Opioid
symbols :
SRNE
save search
Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines
Published:
2022-11-08
(Crawled : 12:00)
- nutriband.com
NTRB
|
$4.04
18K
|
Manufacturing
|
-3.39%
|
O:
-6.56%
H:
6.78%
C:
-0.73%
SRNE
|
$0.024
57K
|
Health Technology
|
-98.62%
|
O:
1.38%
H:
2.72%
C:
0.0%
guidelines
opioid
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial
Published:
2021-12-09
(Crawled : 22:00)
- biospace.com/
SRNE
|
$0.024
57K
|
Health Technology
|
-99.68%
|
O:
1.03%
H:
2.75%
C:
-2.6%
sp-102
trial
therapeutics
opioid
positive
results
phase 3
topline
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R. Program for Sciatica Pain Management Supporting the Potential Use of SP-102 as a Best-in-Class Therapy
Published:
2021-12-09
(Crawled : 17:00)
- globenewswire.com
SRNE
|
$0.024
57K
|
Health Technology
|
-99.68%
|
O:
1.03%
H:
2.75%
C:
-2.6%
sp-102
trial
therapeutics
potential
opioid
positive
therapy
results
phase 3
topline
Scilex Holding Company, a Sorrento Company, Announces Complete Enrollment on Non-Opioid Injectable SP-102 (SEMDEXA™) Phase 3 Pivotal Trial C.L.E.A.R. Program For Sciatica Pain Management
Published:
2021-07-20
(Crawled : 17:00)
- globenewswire.com
SRNE
|
$0.024
57K
|
Health Technology
|
-99.76%
|
O:
1.58%
H:
1.39%
C:
0.25%
opioid
phase 3
trial
injection
enroll
FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients
Published:
2021-07-06
(Crawled : 19:00)
- globenewswire.com
SRNE
|
$0.024
57K
|
Health Technology
|
-99.79%
|
O:
-1.05%
H:
1.06%
C:
-12.02%
treatment
fda
phase 2
opioid
osteoarthritis
trial
fda clearance
Gainers vs Losers
71%
29%
Top 10 Gainers
AGBA
|
News
|
$1.27
217.5%
120M
|
Finance
EGOX
|
$0.0503
39.72%
320M
|
RWOD
|
$10.52
31.56%
5.9M
|
n/a
ZCMD
|
$1.905
31.38%
30M
|
Commercial Services
MRDB
4
|
$0.536
27.65%
2M
|
n/a
BSFC
|
$0.0822
27.64%
75M
|
Manufacturing
TPET
|
$0.4121
25.68%
45M
|
n/a
NVFY
|
$2.65
25.59%
33M
|
Consumer Durables
INDO
|
$5.1
25.0%
15M
|
Energy Minerals
CHRO
|
$1.53
24.9%
100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.